PMI's Earnings Soar 20% Amid Smoke-Free Transition

Ticker: PM · Form: 10-Q · Filed: 2025-10-24T00:00:00.000Z

Sentiment: bullish

Topics: Tobacco, Smoke-Free Products, Earnings Growth, Divestiture, International Markets, Consumer Staples, Shareholder Value

Related Tickers: PM, BTI, MO, IMBBY

TL;DR

**PMI is crushing it with smoke-free products, making bank and leaving traditional tobacco in the dust – buy the dip!**

AI Summary

Philip Morris International Inc. (PM) reported robust financial performance for the nine months ended September 30, 2025, with net revenues increasing by $2.114 billion, or 7.5%, to $30.286 billion from $28.172 billion in the prior year. Net earnings attributable to PMI surged by $1.571 billion, or 20.6%, reaching $9.207 billion compared to $7.636 billion in the same period of 2024. Diluted earnings per share also saw a significant rise, climbing to $5.89 from $4.89, an increase of 20.4%. Operating income grew by $1.376 billion to $11.519 billion, despite a $41 million impairment of goodwill. The company's strategic shift towards Smoke-Free Products (SFPs) is evident, with the sale of Vectura Group Ltd. completed on December 31, 2024, for an upfront cash consideration of GBP 152 million (approximately $191 million). This divestiture led to a segment reporting update in January 2025, integrating Wellness & Healthcare results into the Europe segment and renaming 'PMI Duty Free' to 'PMI Global Travel Retail'. Cash provided by operating activities decreased slightly to $7.524 billion from $8.215 billion, while cash used in investing activities increased significantly to $3.539 billion, primarily due to $2.318 billion in collateral posted for derivatives.

Why It Matters

This strong performance signals PMI's successful pivot towards its Smoke-Free Business (SFB), which is crucial for long-term investor confidence in a declining traditional tobacco market. The significant increase in net earnings and EPS demonstrates effective cost management and revenue growth, even with a $41 million goodwill impairment. For employees, the strategic shift to SFPs indicates a focus on innovation and potentially new job opportunities in less controversial product categories. Customers benefit from a wider range of reduced-harm products, aligning with evolving public health trends. Competitively, PMI's aggressive move into SFPs positions it favorably against rivals still heavily reliant on traditional cigarettes, potentially capturing greater market share in the future of nicotine delivery.

Risk Assessment

Risk Level: medium — While net earnings attributable to PMI increased by $1.571 billion, or 20.6%, to $9.207 billion, the company experienced a substantial increase in cash used in investing activities, rising from $1.533 billion in 2024 to $3.539 billion in 2025. This was largely driven by $2.318 billion in collateral posted for derivatives, up from $159 million, indicating increased financial exposure to market fluctuations. Additionally, accumulated other comprehensive losses widened significantly to $(13.320) billion from $(11.314) billion, primarily due to unrealized currency translation losses of $(1.917) billion.

Analyst Insight

Investors should consider increasing their exposure to PM, given the strong earnings growth and successful strategic pivot to smoke-free products. Monitor the impact of currency fluctuations and derivative collateral requirements, but the core business transformation appears to be driving substantial value.

Financial Highlights

revenue
$30.286B
operating Margin
38.0%
net Income
$9.207B
eps
$5.89
gross Margin
67.6%
revenue Growth
+7.5%

Revenue Breakdown

SegmentRevenueGrowth
Total Net Revenues$30.286B+7.5%

Key Numbers

Key Players & Entities

FAQ

What were Philip Morris International's net revenues for the nine months ended September 30, 2025?

Philip Morris International's net revenues for the nine months ended September 30, 2025, were $30.286 billion, an increase of $2.114 billion from $28.172 billion in the same period of 2024.

How did Philip Morris International's net earnings attributable to PMI change year-over-year?

Net earnings attributable to PMI increased by $1.571 billion, or 20.6%, reaching $9.207 billion for the nine months ended September 30, 2025, compared to $7.636 billion in the prior year.

What was Philip Morris International's diluted earnings per share for the nine months ended September 30, 2025?

Philip Morris International reported diluted earnings per share of $5.89 for the nine months ended September 30, 2025, up from $4.89 in the corresponding period of 2024.

What was the impact of the Vectura Group Ltd. sale on Philip Morris International?

The sale of Vectura Group Ltd. was completed on December 31, 2024, for an upfront cash consideration of GBP 152 million (approximately $191 million). This divestiture led to a segment reporting update in January 2025, integrating Wellness & Healthcare results into the Europe segment.

What is Philip Morris International's strategy regarding smoke-free products?

PMI refers to all its smoke-free products as its Smoke-Free Business (SFB), which includes heat-not-burn, e-vapor, and oral smokeless products. These products are designed to provide nicotine without combusting tobacco, aiming for lower levels of harmful chemicals and reduced harm compared to continued smoking.

What were the changes in Philip Morris International's cash flow from investing activities?

Net cash used in investing activities significantly increased to $3.539 billion for the nine months ended September 30, 2025, from $1.533 billion in 2024. This was primarily due to $2.318 billion in collateral posted for derivatives, compared to $159 million in the prior year.

How did currency translation adjustments affect Philip Morris International's comprehensive earnings?

Unrealized losses from currency translation adjustments, net of income taxes, amounted to $(1.917) billion for the nine months ended September 30, 2025, significantly impacting total other comprehensive earnings (losses) which were $(2.002) billion.

What is the current number of outstanding common stock shares for Philip Morris International?

As of October 17, 2025, there were 1,556,638,749 shares outstanding of Philip Morris International's common stock, no par value per share.

Did Philip Morris International incur any goodwill impairment in the recent quarter?

Yes, Philip Morris International reported an impairment of goodwill of $41 million for the nine months ended September 30, 2025, which was not present in the same period of 2024.

What is the significance of the 'PMI Global Travel Retail' renaming?

Effective in the first quarter of 2025, PMI renamed its 'PMI Duty Free' business to 'PMI Global Travel Retail'. This change reflects an updated segment structure, with the segment now referred to as East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR).

Risk Factors

Industry Context

Philip Morris International operates in a dynamic global tobacco and nicotine market undergoing significant transformation. The industry is characterized by a pronounced shift from traditional combustible products towards reduced-risk alternatives, driven by evolving consumer preferences and increasing regulatory scrutiny worldwide. Competition is intensifying in the smoke-free product category, requiring substantial investment in innovation and market development.

Regulatory Implications

PMI faces a complex and evolving regulatory landscape. Stricter regulations on traditional tobacco products globally continue to shape the market, while new regulatory frameworks are emerging for smoke-free alternatives. The company's strategic focus on SFPs necessitates careful navigation of these diverse and often country-specific regulations, impacting product development, marketing, and market access.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Smoke-Free Products (SFPs)
Products designed to reduce or eliminate the combustion of tobacco or nicotine, such as heated tobacco products and e-cigarettes. (Central to PMI's strategic transformation and future growth.)
Impairment of goodwill
A reduction in the carrying value of goodwill on the balance sheet when its recoverable amount is less than its carrying amount, often due to underperformance of an acquired business. (Indicates a $41 million write-down in the value of acquired assets during the period.)
Diluted earnings per share (EPS)
A measure of profitability that divides net income by the total number of diluted common shares outstanding, including the effect of stock options and convertible securities. (Shows a significant increase to $5.89, reflecting improved profitability on a per-share basis.)
Net revenues
The total amount of income generated from the sale of goods or services, net of returns, allowances, and discounts. For PMI, this is net of excise taxes. (Reported a 7.5% increase to $30.286 billion for the nine-month period.)
Operating income
Profitability from a company's core business operations, calculated as net revenue minus cost of goods sold and operating expenses. (Increased to $11.519 billion, demonstrating improved operational profitability.)
Cash provided by operating activities
The net amount of cash generated from a company's normal business operations. (Decreased to $7.524 billion, suggesting a slight reduction in cash generation from core operations.)
Cash used in investing activities
The net amount of cash used for investments in long-term assets, such as property, plant, and equipment, and financial investments. (Significantly increased to $3.539 billion, largely due to collateral posted for derivatives.)
Accumulated Other Comprehensive Losses (AOCL)
A component of stockholders' equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and pension plan adjustments. (Widened to $(13.320) billion, primarily due to currency translation effects.)

Year-Over-Year Comparison

Philip Morris International has demonstrated strong top-line growth, with net revenues increasing by 7.5% to $30.286 billion for the nine months ended September 30, 2025. This growth is accompanied by a significant 20.6% rise in net earnings attributable to PMI, reaching $9.207 billion, and a corresponding 20.4% increase in diluted EPS to $5.89. Operating income also saw a healthy increase. However, cash provided by operating activities decreased slightly, while cash used in investing activities surged due to derivative collateral, and accumulated other comprehensive losses widened, primarily due to currency translation.

Filing Stats: 4,828 words · 19 min read · ~16 pages · Grade level 14.2 · Accepted 2025-10-24 07:15:20

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) Condensed Consolidated Statements of Earnings for the Nine Months Ended September 30, 2025 and 2024 3 Three Months Ended September 30, 2025 and 2024 4 Condensed Consolidated Statements of Comprehensive Earnings for the Nine Months Ended September 30, 2025 and 2024 5 Three Months Ended September 30, 2025 and 2024 6 Condensed Consolidated Balance Sheets at September 30, 2025 and December 31, 2024 7 – 8 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 9 – 10 Condensed Consolidated Statements of Stockholders' (Deficit) Equity for the Nine Months Ended September 30, 2025 and 2024 11 Three Months Ended September 30, 2025 and 2024 12 Notes to Condensed Consolidated Financial Statements 13 – 54

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 55 – 115

Controls and Procedures

Item 4. Controls and Procedures 116

- OTHER INFORMATION

PART II - OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 116

Risk Factors

Item 1A. Risk Factors 116

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 117

Other Information

Item 5. Other Information 117

Exhibits

Item 6. Exhibits 118 Signature 119 In this report, "PMI," "we," "us" and "our" refer to Philip Morris International Inc. and its subsidiaries. Trademarks and service marks in this report are the registered property of, or licensed by, the subsidiaries of Philip Morris International Inc. and are italicized. 2 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. Philip Morris International Inc. and Subsidiaries Condensed Consolidated Statements of Earnings (in millions of dollars, except per share data) (Unaudited) For the Nine Months Ended September 30, 2025 2024 Net revenues 1 & 2 (Note 13) $ 30,286 $ 28,172 Cost of sales 9,806 9,906 Gross profit 20,480 18,266 Marketing, administration and research costs (Notes 8, 9 & 16) 8,920 8,123 Impairment of goodwill (Note 5) 41 — Operating income 11,519 10,143 Interest expense, net 748 817 Pension and other employee benefit costs (Note 4) 37 44 Earnings before income taxes 10,734 9,282 Provision for income taxes 2,062 2,145 Equity investments and securities (income)/loss, net (Note 13) ( 926 ) ( 852 ) Net earnings $ 9,598 $ 7,989 Net earnings attributable to noncontrolling interests 391 353 Net earnings attributable to PMI $ 9,207 $ 7,636 Per share data (Note 7): Basic earnings per share $ 5.90 $ 4.90 Diluted earnings per share $ 5.89 $ 4.89 (1) Includes net revenues from related parties of $ 3,387 million and $ 2,866 million for the nine months ended September 30, 2025 and 2024, respectively. (2) Net revenues are shown net of excise tax on products. For the nine months ended September 30, 2025 and 2024, excise tax on products was $ 39,495 million and $ 38,535 million, respectively. See notes to condensed consolidated financial statements. 3 Table of Contents Philip Morris International Inc. and Subsidiaries Condensed Consolidated Statements of Earnings (in millions of dollars, except per share data) (Unaudited) For the Three Months Ended September 30, 2025 2024 Net revenues 1 & 2 (Note 13) $ 10,845 $ 9,911 Cost of sales 3,487 3,366 Gross profit 7,358 6,545 Marketing, administration and research costs (Notes 8 & 9) 3,095 2,891 Operating income 4,263 3,654 Interest expense, net 230 189 Pension and other employee benefit costs (Note 4) 14 15 Earnings before income taxes 4,019 3,450 Provision for incom

View on Read The Filing